Title
Agreeing to the amended Minnesota Opioids State-Subdivision Memorandum of Agreement and authorizing City staff to execute all necessary documents to ensure the City's participation in the Teva Pharmaceuticals, Allergan PLC, Walmart Inc., CVS Health Corp., and Walgreens Boots Alliance Inc. Settlements, including the participation Agreement and accompanying Release and the Amended State-Subdivision Agreement.
Body
Agreeing to the Amended Minnesota Opioids State-Subdivision Memorandum of Agreement
WHEREAS, the State of Minnesota and numerous Minnesota cities and counties are engaged in nationwide civil litigation against opioid supply chain participants related to the opioid crisis; and
WHEREAS, in 2021, the State of Minnesota, the City of Saint Paul, and numerous other Minnesota cities and counties previously agreed to the Minnesota Opioids State-Subdivision Memorandum of Agreement (“State-Subdivision Agreement”), which governed distribution of opioid settlement funds from multistate agreements with pharmaceutical distributors McKesson, Cardinal Health, and AmerisourceBergen, as well as opioid manufacturer Johnson & Johnson; and
WHEREAS, the State-Subdivision Agreement prioritizes flexibility for how local governments may use opioid settlement funds for opioids abatement and remediation, and which provides for 75% of the settlement funds to be distributed directly to local governments and 25% of the settlement funds to be distributed directly to the State; and
WHEREAS, the State of Minnesota and numerous Minnesota cities and counties have begun to receive distributions of settlement funds from the prior multistate settlement agreements, pursuant to the State-Subdivision Agreement; and
WHEREAS, the Minnesota Attorney General has signed on to several additional multistate settlement agreements with manufacturers Teva Pharmaceuticals and Allergan plc, as well as pharmacy companies Walmart Inc., CVS Health Corp., and Walgreens Boots Alliance Inc., b...
Click here for full text